Monitoring of in-process bioburden of pharmaceutical components, containers and closures, intermediates, drug substances and drug products are essential elements of the overall contamination control program for appropriate process control of both non-sterile and sterile products.

The objective of this live, interactive training webinar is to obtain an enhanced understanding of the monitoring of bioburden, its inherent methods, and limitations to assure that the test is being applied as appropriate per United States Pharmacopeia and how to interpret the final result.  It will also consider methods of sterilization and consideration of component bioburden and endotoxin.

Find out more / register here: